Recently, the ISR was shown to also be induced via haem-regulated inhibitor kinase activation as a result of MOMP and cytochrome c release in cancer cells which recover from transient treatment with cytotoxic concentrations of BH3 mimetics, resulting in cells with persister cell features and metastatic potential9. Here, CYCS is linked to cancer.